Gastric sleeve surgery is one of the most commonly performed bariatric procedures in the UK, offering a long-term solution for people living with severe obesity. Also known as sleeve gastrectomy, the operation permanently removes around 75–80% of the stomach, creating a narrow, banana-shaped sleeve that restricts food intake and alters hunger-regulating hormones. Whether you are exploring NHS eligibility, weighing up the risks, or preparing for life after surgery, this guide covers everything you need to know — from how the procedure works to long-term follow-up care and lifestyle changes.

What Is Gastric Sleeve Surgery and How Does It Work

Gastric sleeve surgery removes 75–80% of the stomach laparoscopically, creating a small sleeve that restricts food intake and reduces ghrelin, the hunger hormone, while increasing appetite-suppressing gut hormones such as GLP-1.

Gastric sleeve surgery, medically known as a sleeve gastrectomy, is a type of bariatric (weight-loss) surgery in which approximately 75–80% of the stomach is permanently removed, leaving a narrow, tube-shaped 'sleeve' roughly the size and shape of a banana. The procedure is performed laparoscopically (keyhole surgery) under general anaesthetic, typically taking between 60 and 90 minutes.

The mechanism by which gastric sleeve surgery promotes weight loss is multifactorial:

• Restriction: The significantly reduced stomach capacity means patients feel full after consuming much smaller portions of food.

• Hormonal changes: The portion of the stomach removed contains cells that produce ghrelin, often called the 'hunger hormone'. Reducing ghrelin levels helps to suppress appetite. In addition, sleeve gastrectomy leads to increases in gut hormones such as GLP-1 (glucagon-like peptide-1) and PYY (peptide YY), which further reduce appetite and can improve glycaemic control — an important benefit for patients with type 2 diabetes.

Unlike gastric bypass surgery, the gastric sleeve does not reroute or alter the intestines, meaning food continues to pass through the digestive tract in the usual way. However, micronutrient deficiencies can still occur after sleeve gastrectomy — primarily due to reduced food intake, reduced gastric acid production, and altered digestive physiology rather than intestinal malabsorption. This makes lifelong nutritional monitoring and supplementation necessary.

Gastric sleeve surgery is considered major surgery and is irreversible — the removed portion of the stomach cannot be restored. According to NHS and published bariatric data, patients typically lose between 50% and 70% of their excess body weight within the first 18 to 24 months following surgery, though outcomes vary depending on lifestyle adherence and individual factors.

Who Is Eligible for Gastric Sleeve Surgery on the NHS

NHS eligibility requires a BMI of 40 or above, or 35–39.9 with a significant obesity-related condition, after completing a Tier 3 supervised weight management programme, in line with NICE CG189.

Access to gastric sleeve surgery on the NHS is governed by criteria set out in NICE Clinical Guideline CG189 (Obesity: identification, assessment and management), NHS England commissioning policies, and local integrated care board (ICB) policies, which can vary by region.

Generally, NHS eligibility requires that a patient:

• Has a BMI of 40 or above, or a BMI of 35–39.9 alongside a significant obesity-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea.

• Has tried and not achieved or maintained clinically significant weight loss through supervised lifestyle interventions, including dietary changes and increased physical activity, typically delivered through a Tier 3 specialist weight management service.

• Is fit for surgery and general anaesthesia, as assessed by a multidisciplinary team (MDT) including a surgeon, dietitian, psychologist, and specialist nurse.

• Is committed to long-term follow-up and lifestyle changes post-operatively.

• Does not have contraindications such as untreated severe psychiatric illness or active substance misuse.

NICE CG189 also recommends that adults with a BMI of 35 or above and recent-onset type 2 diabetes be offered an expedited assessment for bariatric surgery, as surgery may offer the best chance of diabetes remission. Assessment should also be considered for adults with a BMI of 30–34.9 with recent-onset type 2 diabetes. Bariatric surgery may be considered as a first-line option for adults with a BMI over 50.

Importantly, for people from some minority ethnic groups (for example, those of South Asian, Chinese, or Black African or Caribbean family background), NICE recommends using BMI thresholds approximately 2.5 kg/m² lower when assessing obesity-related risk and considering interventions.

The usual NHS pathway involves referral from a GP to a Tier 3 specialist weight management service for intensive, multidisciplinary non-surgical management before onward referral to a Tier 4 surgical service. Pre-surgical requirements typically include smoking cessation and optimisation of relevant comorbidities.

Patients under 18 may be considered in exceptional circumstances at specialist paediatric centres. NHS waiting lists for bariatric surgery can be lengthy, and some patients choose to access the procedure privately. Private costs in the UK typically range from £8,000 to £15,000. Regardless of funding route, thorough pre-operative assessment remains essential.

What to Expect Before, During and After the Procedure

Before surgery, patients follow a liver-shrinking diet for two to four weeks; the laparoscopic procedure takes 60–90 minutes, and dietary recovery progresses from fluids to solid foods over approximately six weeks.

Before surgery, patients undergo a comprehensive pre-operative assessment coordinated by a specialist bariatric MDT. Investigations may include blood tests, an ECG, and sleep studies if obstructive sleep apnoea is suspected. An upper gastrointestinal endoscopy (OGD) may be performed where clinically indicated — for example, if the patient has symptoms of gastro-oesophageal reflux, anaemia, or other risk factors — but is not carried out routinely in all patients. Most patients are required to follow a high-protein, low-calorie liver-shrinking diet for two to four weeks prior to surgery. This reduces liver size, making the procedure safer and technically easier.

During the procedure, the surgeon makes several small incisions in the abdomen and inserts a laparoscope and surgical instruments. The majority of the stomach is stapled and removed. The remaining sleeve is checked for leaks before the incisions are closed. Patients are usually admitted to hospital for one to two nights post-operatively.

After surgery, recovery progresses through clearly defined dietary stages, though exact timelines vary by centre and should always follow the guidance of the local bariatric team and dietitian:

• Week 1–2: Fluids only (water, diluted juice, thin soups).

• Week 3–4: Pureed and soft foods.

• Week 5–6: Gradual reintroduction of solid foods.

• Beyond 6 weeks: A balanced, nutrient-dense diet in small portions.

Patients are advised to eat slowly, chew thoroughly, and avoid drinking with meals. Because reduced food intake, lower gastric acid production, and altered digestive physiology can lead to micronutrient deficiencies, lifelong vitamin and mineral supplementation is required. In line with guidance from the British Obesity and Metabolic Surgery Society (BOMSS), this typically includes a bariatric-specific multivitamin and mineral supplement, plus additional calcium with vitamin D, iron, and vitamin B12 as indicated — with the route and frequency of supplementation determined by the individual centre's protocol. Most people return to light activities within two to four weeks and to full activity within six to eight weeks.

Risks, Complications and Long-Term Considerations

Short-term risks include staple line leak and blood clots; long-term risks include GORD, nutritional deficiencies, gallstones, and weight regain, with red-flag symptoms such as chest pain or vomiting blood requiring immediate emergency care.

As with any major surgical procedure, gastric sleeve surgery carries both short-term and long-term risks. Patients should be fully informed of these during the consent process.

Short-term risks include:

• Staple line leak — a serious complication occurring in approximately 0.5–2% of cases in contemporary UK practice, requiring urgent medical attention.

• Bleeding at the staple line or from surrounding vessels.

• Blood clots (deep vein thrombosis or pulmonary embolism), mitigated by early mobilisation and prophylactic anticoagulation.

• Infection, including wound infection or intra-abdominal abscess.

• Anaesthetic complications, particularly relevant in patients with obesity-related comorbidities.

• Thiamine (vitamin B1) deficiency, which can occur if prolonged vomiting prevents adequate oral intake in the early post-operative period.

Longer-term considerations include:

• Gastro-oesophageal reflux disease (GORD): A significant proportion of patients experience new or worsened acid reflux following sleeve gastrectomy. This may require medical treatment, further investigation, or in selected cases conversion to a gastric bypass.

• Stricture or stenosis of the sleeve, which can cause persistent difficulty swallowing or vomiting and may require endoscopic or surgical intervention.

• Gallstones: Rapid weight loss increases the risk of gallstone formation. Patients should be aware of symptoms and seek prompt assessment if they develop right upper abdominal pain.

• Gastrointestinal bleeding or ulceration, which may present as black tarry stools or vomiting blood.

• Nutritional deficiencies: Lifelong supplementation and monitoring are required to prevent deficiencies in iron, vitamin B12, vitamin D, folate, and other micronutrients.

• Weight regain: Some patients experience weight regain after two to five years, particularly if dietary and behavioural changes are not sustained.

• Psychological adjustment: Changes in body image, eating behaviour, and social relationships can be challenging and may require ongoing psychological support.

• Pregnancy planning: Patients are advised to avoid conception for at least 12–18 months after surgery, when weight loss is most rapid and nutritional status may be less stable. Preconception counselling and review by the bariatric team are recommended for anyone planning a pregnancy.

Urgent red flags — seek emergency help immediately (call 999 or go to A&E) if you experience:

• Sudden severe chest pain or shortness of breath

• Coughing or vomiting blood

• Sudden calf pain or swelling

• Black or tarry stools

• Signs of severe dehydration or inability to keep any fluids down

Contact your bariatric team promptly for persistent vomiting, rapid heart rate, signs of wound infection, or symptoms suggestive of nutritional deficiency such as fatigue, hair loss, or numbness in the extremities.

Support, Follow-Up Care and Life After Gastric Sleeve

Structured follow-up includes regular blood tests, dietetic and psychological support, and GP management of comorbidities; NSAIDs should be avoided, and adults should aim for at least 150 minutes of moderate activity per week.

Long-term success following gastric sleeve surgery depends not only on the procedure itself but on sustained engagement with follow-up care and meaningful lifestyle change. NHS bariatric programmes typically provide structured follow-up appointments at one month, three months, six months, and annually thereafter, though this varies by centre. Patients discharged from the surgical service should continue to receive shared care through their GP or Tier 3 service.

Follow-up care generally includes:

• Regular blood tests to monitor nutritional status. In line with BOMSS guidance, this typically includes full blood count, ferritin, vitamin B12, vitamin D, folate, corrected calcium, PTH (parathyroid hormone), urea and electrolytes (U&Es), and liver function tests (LFTs). Testing for zinc, copper, or selenium may also be considered where clinically indicated.

• Dietetic support to guide dietary progression, address nutritional concerns, and support healthy eating habits.

• Psychological support, which may include cognitive behavioural therapy (CBT) or counselling to address emotional eating, body image concerns, or mental health conditions that can emerge or persist post-operatively.

• GP involvement for ongoing management of comorbidities such as type 2 diabetes or hypertension, many of which may improve significantly or resolve following surgery.

Medicines after surgery: Many bariatric centres prescribe a proton pump inhibitor (PPI) routinely in the early post-operative period to reduce the risk of ulceration. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen should be avoided or used only with caution due to the increased risk of gastric ulceration; patients should seek advice from their bariatric team or GP before taking them. Alcohol sensitivity may be increased after sleeve gastrectomy, and patients are advised to exercise caution.

Lifestyle changes that support long-term outcomes include regular physical activity — in line with the UK Chief Medical Officers' guidelines, adults should aim for at least 150 minutes of moderate-intensity activity per week alongside muscle-strengthening activities on two or more days per week — as well as mindful eating practices and avoiding high-calorie liquid foods that can bypass the restriction of the sleeve.

Many patients report significant improvements in quality of life, mobility, self-esteem, and resolution of obesity-related health conditions. However, it is important to approach surgery with realistic expectations — it is a powerful tool, not a cure. Peer support groups, both in-person and online, can provide valuable community and motivation throughout the journey. Patients are encouraged to remain in contact with their bariatric team and not to hesitate in seeking help if difficulties arise at any stage.

If you experience any unexpected symptoms that you think may be related to a medicine or medical device, you can report this via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions